| Trial ID: | L1248 |
| Source ID: | NCT00257920
|
| Associated Drug: |
Zemplar® Injection
|
| Title: |
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00257920/results
|
| Conditions: |
Chronic Kidney Disease, Stage 5|Secondary Hyperparathyroidism
|
| Interventions: |
DRUG: Zemplar® injection|DRUG: Hectorol® injection
|
| Outcome Measures: |
Primary: Calcium Absorption Fractions Analyzed by Analysis of Variance (ANOVA), Calcium Absorption Fraction obtained at the end of Period 1 \& Period 2, 42 Days | Secondary: Calcium Absorption Fractions Analyzed by Mixed Model, Calcium Absorption Fraction obtained at the end of Period 1 \& Period 2, 42 Days
|
| Sponsor/Collaborators: |
Sponsor: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
41
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-06
|
| Completion Date: |
|
| Results First Posted: |
2009-05-20
|
| Last Update Posted: |
2009-12-24
|
| Locations: |
Bellevue, Nebraska, 68123, United States|Omaha, Nebraska, 68131, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00257920
|
